Addiction in focus: molecular mechanisms, model systems, circuit maps, risk prediction and the quest for effective interventions

Affiliations

¹ Department of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, The Leon and Norma Hess Center for Science and Medicine, New York, NY, USA.
² Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives, Université de Strasbourg, Strasbourg, France.
³ Behavioural and Clinical Neuroscience Institute and Department of Psychology, University of Cambridge, Cambridge, UK.
⁴ The Cognitive Neurophysiology Laboratory, Department of Neuroscience, The Ernest J. Del Monte Institute for Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Editorial

Rita Z Goldstein et al. Eur J Neurosci. 2019 Aug.

. 2019 Aug;50(3):2007-2013.

doi: 10.1111/ejn.14544.

¹ Department of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, The Leon and Norma Hess Center for Science and Medicine, New York, NY, USA.
² Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives, Université de Strasbourg, Strasbourg, France.
³ Behavioural and Clinical Neuroscience Institute and Department of Psychology, University of Cambridge, Cambridge, UK.
⁴ The Cognitive Neurophysiology Laboratory, Department of Neuroscience, The Ernest J. Del Monte Institute for Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

No abstract available

Cited by

Social context and drug cues modulate inhibitory control in cocaine addiction: involvement of the STN evidenced through functional MRI.
Terenzi D, Simon N, Gachomba MJM, de Peretti JL, Nazarian B, Sein J, Anton JL, Grandjean D, Baunez C, Chaminade T. Terenzi D, et al. Mol Psychiatry. 2024 Dec;29(12):3742-3751. doi: 10.1038/s41380-024-02637-y. Epub 2024 Jun 26. Mol Psychiatry. 2024. PMID: 38926543 Free PMC article.

1. Aharonovich E, Nunes E & Hasin D (2003) Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend, 71, 207–211. - PMC - PubMed
1. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A & Nunes EV (2006) Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend, 81, 313–322. - PubMed
1. Alia-Klein N, Parvaz MA, Woicik PA, Konova AB, Maloney T, Shumay E, Wang R, Telang F et al. (2011) Gene 9 disease interaction on orbitofrontal gray matter in cocaine addiction. Arch. Gen. Psychiatry, 68, 283–294. - PMC - PubMed
1. Anand KJ & Campbell-Yeo M (2015) Consequences of prenatal opioid use for newborns. Acta Paediatr, 104, 1066–1069. - PubMed
1. Anderson EM, Penrod RD, Barry SM, Hughes BW, Taniguchi M & Cowan CW (2019) It is a complex issue: emerging connections between epigenetic regulators in drug addiction. Eur. J. Neurosci, 50, 2477–2491. - PubMed